CECCHETTI, VIOLETTA
 Distribuzione geografica
Continente #
NA - Nord America 322
EU - Europa 91
AS - Asia 38
AF - Africa 19
Totale 470
Nazione #
US - Stati Uniti d'America 322
IT - Italia 76
SG - Singapore 25
CI - Costa d'Avorio 18
CN - Cina 4
GB - Regno Unito 4
VN - Vietnam 4
UA - Ucraina 3
AT - Austria 2
HK - Hong Kong 2
IN - India 2
AZ - Azerbaigian 1
BE - Belgio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
FI - Finlandia 1
MA - Marocco 1
NL - Olanda 1
SI - Slovenia 1
Totale 470
Città #
Chandler 79
Napoli 27
Boston 16
Lawrence 16
Ashburn 14
Des Moines 13
Millbury 13
Dearborn 12
Singapore 10
Naples 7
Wilmington 6
Dong Ket 4
Falls Church 4
Jacksonville 3
Novara 3
Perugia 3
Castel San Giorgio 2
Fairfield 2
Foligno 2
Giugliano in Campania 2
Hong Kong 2
Pune 2
Reggio Nell'emilia 2
Riverside 2
Vienna 2
Amsterdam 1
Aversa 1
Baku 1
Bari 1
Bastia 1
Beijing 1
Brussels 1
Changsha 1
Council Bluffs 1
Dallas 1
Hefei 1
Indianapolis 1
La Canada Flintridge 1
Lappeenranta 1
Latina 1
Ljubljana 1
London 1
Madyouna 1
Nanchang 1
Norwalk 1
Palermo 1
Redmond 1
Tallinn 1
Woodbridge 1
Totale 272
Nome #
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 37
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 36
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 36
Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor 35
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 32
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 30
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 30
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 29
Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium 28
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 28
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 28
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 28
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 25
The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors 22
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 21
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 21
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 20
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives 19
Totale 505
Categoria #
all - tutte 1.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.801


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 22 2 9 8 0 0 5 3 1
2020/202171 7 0 1 1 9 22 5 0 19 1 1 5
2021/2022102 0 2 0 3 2 2 4 6 2 0 35 46
2022/2023183 19 4 12 22 29 22 2 21 38 1 11 2
2023/202499 5 23 3 11 4 2 1 21 2 2 25 0
Totale 505